Skip to main content
. 2021 Dec 9;12(3):774–784. doi: 10.1016/j.jceh.2021.12.001

Table 2.

Response of the Tumor to Radiofrequency Ablation in Relation to the Clinical, Biochemical, Radiological, and Pathological Parameters.

Parameter Tumor Response to RFA
P Value Test of Significance
Responder (n = 36) Nonresponder (n = 14)
Age
 Range 41–75 46–72
 Median 54.50 51.50 P = 0.279 U = 202.00
 Mean ± SD 56.22 ± 7.885 54.14 ± 7.702
Gender
 Male 32 (88.9%) 10 (71.4%) FEP = 0.197
 Female 4 (11.1%) 4 (28.6%)
Child-Turcotte-Pugh class
 A 2 (22.2%) 2 (40.0%) FEP = 0.580
 B 7 (77.8%) 3 (60.0%)
Serum alpha-fetoprotein
 Range 1–2000 5.42–815
 Median 40.00 109.00 P = 0.027∗ U = 149.50
 Mean ± SD 126.45 ± 333.051 220.48 ± 253.149
Number of tumors
 Mean value 1.36 ± 0.683 1.71 ± 0.726 P = 0.056 U = 178.00
 Distribution:
 1 nodule 27 (75.0%) 6 (42.9%)
 2 nodules 5 (13.9%) 6 (42.9%) P = 0.064 χ2 = 5.507
 ≥3 nodules 4 (11.1%) 2 (14.3%)
Size of tumors
 Mean value 3.31 ± 0.905 3.10 ± 0.875 P = 0.579 U = 220.00
 Distribution:
 <2 cm 2 (5.6%) 1 (7.1%)
 2–3 cm 14 (38.9%) 6 (42.9%) P = 0.933 χ2 = 0.140
 >3 cm–≤5 cm 20 (55.6%) 7 (50.0%)
Pathological grade of tumors
 Grade I 9 (25.0%) 0 (0.0%)
 Grade II 24 (66.7%) 7 (50.0%) P = 0.002∗ χ2 = 12.702
 Grade III 3 (8.3%) 7 (50.0%)

U: Mann–Whitney test.

χ2: Chi-square test.

FE: Fisher’s Exact test.

P: P value for association between different categories.

∗: Statistically significant at P ≤ 0.05.